维普中文期刊产品整合服务
36篇 您的检索式:作者名="CICE G"
    题名 作者 年代 出处 被引量
1Effects of telmisartan added to angiotensin-converting enzyme inhibitors on mortality and morbidity in hemodialysis patients with chronic heart fail- ure:a double-blind, placebo-controlled trial 显示文摘Cice G Di Benedetto A D' Isa S 2010J Am Coil Cardio12010,56,:1
2Effects of telmisartan added to Angiotensin-converting enzyme inhibitors on mor- tality and morbidity in hemodialysis patients with chronic heart failure: a double-blind, placebo-controlled trial 显示文摘Cice G Benedetto A D'lsa S 2010J Am Coil Cardiol2010,56,21:1
3Efficacy of carvedilol on complex ventricular arrhythmias in dilated cardiomyopathy: Doubleblind, randomized, placebo-controlled study 显示文摘Cice G Tagliamonte E Ferrara L 2000Eur Heart J2000,21,:1
4Effect of Carvedilol,Ivabradine or their combination on exercise capacity inpatients with Heart Failure (theCARVIVA HF trial)显示文摘Volterrani M Cice G Caminiti G 2011IntJ Cardiol2011,151,2:1
5Enzymatic determinationof total serum cholesterol 显示文摘Charles C Allain Lucy S Poon Cicely S G Chan et cd 1974ClinicalChemistry1974,20,4:1
6Carvedilol increases two-year survivalin dialysis patients with dilated cardiomyopathyA prospective, placebo-controlled trial显示文摘Cice G Ferrara L D'Andrea A 2003Journal of the American College of Cardiology2003,41,9:1
7Carvedilol increases two-year survival in dialysis patients with dilated cardiomyopathy:a prospective,placebo-controlled trial显示文摘Cice G Ferrara L D Andrea A 2003J Am Coll Cardiol2003,41,:1
8Carvedilol increases twoyear survivalin dialysis patients with dilated cardiomyopathy:a prospective,placebo-controlled trial显示文摘 Ferrara L DAndrea A 2003J Am Coll Cardiol2003,41,:1
9Carvedilol increases two-year survival in dialysis patients with dilated cardiomyopathy : a prospective, placebo-controlled trial 显示文摘Cice G Ferrara L D?kndrea A 2003J Am Coil Cm''diol2003,41,9:1
10Syndrome X ed angina microvascolare 显示文摘Ferrara L Tagliamonte E Cice G 1998Minerva Cardioangiol1998,46,6:1
11Heart rate as independent prognostic factor for mortality in normotensive hemodialysed patients显示文摘Cice G Di Benedetto A D′Andrea A 2008J Nephrol2008,21,5:1
12Heart rate as independ- ent prognostic factor for mortality in norrnotensive hemodialysed pa- tients显示文摘Cice G Di Benedetto A D'Andrea A 2008J Nephrol2008,21,5:1
13Carvedilol increases two-year survialin dialysis patients with dilated cardiomyopathy:a prospective,placebo-controlled trial显示文摘CICE G FERRARA L D'ANDREA A 2003J Am Coil Cardiol2003,41,9:1
14Heart rate as independent prognostic factor for mortality in normotensive hemodialysed patients显示文摘Cice G Di Benedetto A D′Andrea A 2008J Nephrol2008,21,5:1
15Efficancy of carve dilol on complex ventricular arrhjthamios in dilated cardiomyopathy: Double blind, randomized, placebo-controlled study显示文摘Cice G TagliamonteX E Ferrara L 2000Eur Heart J2000,21,:1
16Effects of telmisartan added to Angiotensin-converting enzyme inhibitors on mor- tality and morbidity in hemodialysis patients with chronic heart failure a double-blind, placebo-controlled trial显示文摘Cice G Di Benedetto A D'Isa S 2010J Am Coil Cardiol2010,56,21:1
17Heart rate as in- dependent prognostic factor for mortality in normotensive he- modialysed patients显示文摘Cice G Di Benedetto A D'Andrea A 2008J Nephrol2008,21,5:1
18Carvedilol increases two-year survivalin dialysis patients with dilated catdiomyopathy:a prospective,placebo-controlled trial显示文摘Cice G Ferrara L D'Andrea A 2003J Am Coll Cardiol2003,41,9:1
19Carvedilol increases two-year survivalin dialysis patients with dilated cardiomyopathy:a prospective, placebo-controlled trial显示文摘Cice G Ferrara L D'Andrea A 2003J Am Coll Cardiol2003,41,9:1
20Carvedilol increases two-year survival in dialysis patients with dilated cardiomyopathy:a prospective,placebo-controlled trial显示文摘CICE G FERRARA L D'ANDREA A 2003J Am Coll Cardiol2003,41,9:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费